Seismic Therapeutic
Seismic Therapeutic is a biotech company using its IMPACT platform and machine learning to develop therapies for autoimmune diseases.
Secondary Market Price
How Seismic Therapeutic Measures Up
To help you manage your Seismic Therapeutic equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Seismic Therapeutic's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Seismic Therapeutic Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Seismic Therapeutic's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Seismic Therapeutic is a biotechnology company that integrates machine learning into the discovery and development of immunology therapies. The company utilizes its proprietary IMPACT platform, which combines machine learning with structural biology, protein engineering, and translational immunology, to build a pipeline of biologics. These efforts are focused on controlling dysregulated adaptive immunity to address various autoimmune diseases. A privately held company based in Watertown, MA, Seismic Therapeutic is co-founded by its CEO, Jo Viney, Ph.D. The company has completed three funding rounds, the most recent being a Series B round in October 2024 that raised $25 million.
The company plans to continue the development of its preclinical pipeline for autoimmune and inflammatory diseases. Recent activities include presentations at major industry events, such as the J.P. Morgan Healthcare Conference and the Antibody Engineering & Therapeutics US Conference. At these events, company leadership and scientists have shared research on topics including engineering for optimal receptor agonism and the development of IgE-cleaving enzymes for treating allergies. For example, one presentation detailed the structure-based design of a protease engineered to degrade IgE, a key factor in allergic reactions.
- Bessemer Venture Partners
- Amgen Ventures
- Codon Capital
- Alexandria Venture Investments
- Gaingels
- GC&H
- Timothy A. Springer
- Lightspeed Venture Partners
- Polaris Partners
- Boxer Capital
- GV
- Samsara BioCapital
- Co-Founder, Jo Viney
- Co-Founder, Alan Crane
- Co-Founder, Timothy A. Springer
- Co-Founder, Debora Marks
- Co-Founder, Jeffrey V. Ravetch
- Co-Founder, Andrew Kruse
- Co-Founder, Eric Sundberg
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Seismic Therapeutic worth joining?
Deciding to join a startup like Seismic Therapeutic requires careful consideration of its growth potential, leadership, and your personal career goals. To fully understand the value of your potential equity compensation, you can use tools like Prospect to model different financial outcomes and make an informed decision.
What should I do with my Seismic Therapeutic stock?
Managing private stock in a company like Seismic Therapeutic involves complex decisions around when to exercise options and how to plan for taxes. Platforms like Prospect offer personalized strategies and tools to help you optimize your equity decisions and maximize your potential post-tax returns.
Can you sell Seismic Therapeutic stock?
As a private company, selling Seismic Therapeutic stock is typically possible through secondary markets or company-organized tender offers, though it's more complex than selling public shares. Tools like Prospect can help you navigate these events with features like tender offer analysis and access to secondary market pricing data.
How can I find the value of my Seismic Therapeutic stock?
The official value of private stock is determined by a 409A valuation, but its future market value can be difficult to predict. You can use platforms like Prospect, which leverage proprietary predictive models and secondary market data to help you forecast your equity's potential worth.
What is Seismic Therapeutic's equity worth?
The ultimate worth of your Seismic Therapeutic equity depends on the company's future success and potential liquidity events like an IPO or acquisition. To better understand the range of possible outcomes, you can use Prospect's predictive models to forecast your equity's value under different scenarios.
What is Seismic Therapeutic's stock ticker symbol?
Seismic Therapeutic is a private company, so it does not have a stock ticker symbol. Ticker symbols are only assigned to companies when they become publicly traded on a stock exchange.
Can I buy or sell Seismic Therapeutic stock?
As a private company, selling your Seismic Therapeutic stock is often possible through secondary markets or tender offers, while buying shares is typically limited to accredited investors or employees. Platforms like Prospect provide tools to help employees navigate selling opportunities and make tax-optimal decisions.
What is the criteria to buy or invest in Seismic Therapeutic stock?
Investing in a private company like Seismic Therapeutic is typically restricted to accredited investors participating in funding rounds or employees who receive equity compensation. If you are an employee, Prospect can help you manage and optimize the value of the equity you've been granted.
